Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Digestive Pathophysiology Unit, Baggiovara Hospital, Modena, Italy.
Aliment Pharmacol Ther. 2021 Aug;54(4):412-418. doi: 10.1111/apt.16481. Epub 2021 Jun 28.
BACKGROUND: The Lyon Consensus delineates impedance-pH parameters that can demonstrate/exclude gastro-oesophageal reflux disease (GERD). In patients with acid exposure time between 4% and 6%, GERD diagnosis has been considered inconclusive. In these cases, mean nocturnal baseline impedance (MNBI) and post-reflux swallow-induced peristaltic wave (PSPW) index may either confirm or refute GERD diagnosis and represent predictors of proton pump inhibitor (PPI) response. AIMS: To investigate the diagnostic yield of MNBI and PSPW index and their relationship with PPI response in patients with inconclusive GERD diagnosis. METHODS: Review of impedance-pH tracings from PPI responder/non-responder patients with typical reflux symptoms. Multivariate regression analysis was performed to determine the association of MNBI and PSPW index to PPI response. RESULTS: Among 233 patients evaluated, 145/233 (62.2%) were PPI responders; 62 had conclusive and 65 inconclusive evidence of GERD, 46 had reflux hypersensitivity, and 60 functional heartburn. Abnormal MNBI and PSPW index were significantly more frequent in inconclusive GERD as compared to the functional heartburn group (P < 0.001). Within the inconclusive GERD group, 35/65 (54%) patients were PPI responders and displayed a significantly higher proportion of cases with pathological MNBI or PSPW index as compared to non-responders (32/35 [91.4%] and 30/35 [85.7%] vs 9/30 [30%] and 7/30 [23.3%], P < 0.001). By multivariate analysis, pathological PSPW index and/or MNBI values were significantly associated with PPI response in all groups. CONCLUSIONS: The present study highlights the value of MNBI and PSPW index as adjunctive metrics in characterising patients with inconclusive evidence of GERD and identifying those responsive to PPI treatment.
背景:里昂共识界定了可证明/排除胃食管反流病(GERD)的阻抗-pH 参数。在酸暴露时间在 4%和 6%之间的患者中,GERD 诊断被认为不确定。在这些情况下,平均夜间基线阻抗(MNBI)和反流后吞咽诱导蠕动波(PSPW)指数可以确认或否定 GERD 诊断,并作为质子泵抑制剂(PPI)反应的预测指标。
目的:研究 MNBI 和 PSPW 指数在 GERD 诊断不确定患者中的诊断价值及其与 PPI 反应的关系。
方法:回顾性分析 PPI 反应者/非反应者具有典型反流症状的阻抗-pH 描记图。进行多变量回归分析以确定 MNBI 和 PSPW 指数与 PPI 反应的相关性。
结果:在评估的 233 名患者中,145/233(62.2%)为 PPI 反应者;62 例有明确证据,65 例有不确定的 GERD 证据,46 例有反流过度敏感,60 例有功能性烧心。与功能性烧心组相比,GERD 诊断不确定组的异常 MNBI 和 PSPW 指数更为常见(P<0.001)。在 GERD 诊断不确定组中,35/65(54%)患者为 PPI 反应者,与非反应者相比,病理性 MNBI 或 PSPW 指数的病例比例显著更高(32/35[91.4%]和 30/35[85.7%]与 9/30[30%]和 7/30[23.3%],P<0.001)。通过多变量分析,病理性 PSPW 指数和/或 MNBI 值与所有组的 PPI 反应显著相关。
结论:本研究强调了 MNBI 和 PSPW 指数作为辅助指标在 GERD 证据不确定患者中的价值,并可识别对 PPI 治疗有反应的患者。
Neurogastroenterol Motil. 2023-5
Dig Dis Sci. 2017-8
Digestion. 2025-6-25
Cureus. 2025-2-10
Gastro Hep Adv. 2022-4-5
Transl Gastroenterol Hepatol. 2024-7-1
Neurogastroenterol Motil. 2024-3
Neurogastroenterol Motil. 2022-2
Clin Gastroenterol Hepatol. 2021-9
J Neurogastroenterol Motil. 2020-7-30
J Neurogastroenterol Motil. 2020-9-30
Neurogastroenterol Motil. 2020-3